ArticleScientific reports2026
Multiplexing antibiotic screening assay in droplet microfluidics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmental samples contain complex microbial communities hiding a treasure trove of active compounds. However, screening for active natural products from environmental samples is challenging due to inefficient cultivation techniques and a lack of proper screening platforms. For empowering antibiotic screening assays from complex microbial communities, we have developed and optimized a droplet-based platform with multiplexing capability. A cultivation strategy for bacteria in picoliter droplets was combined with phenotypic screening using multiple whole-cell reporter species. A mixture of two different fluorescently labelled reporter strains, one Gram-positive and one Gram-negative, was picoinjected to each of millions of picoliter cultures, which were screened for inhibiting activity based on the independent survival signals of each reporter species. Proof-of-concept experiments demonstrate efficient detection, selection, and recovery of a model Streptomyces strain from a synthetic mixture according to the specific inhibition of the reporter strains by the produced antibiotic. Subsequently, the established platform was successfully applied to screen environmental microbial communities from soil samples. This approach showcases multiplexing capabilities for screening assays in microfluidic droplets in order to simultaneously screen for new bioactive compounds with various inhibition profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.